Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Medical School

Boston University School of Medicine

1979, Boston, MA

Internship

University Hospital of Arkansas

1980, Little Rock, AR

Residency

University Hospital of Arkansas

1983, Little Rock, AR

Fellowship

Children's Hospital of Pittsburgh

1984, Pittsburgh, PA

Graduate School

MPH

Harvard School of Public Health

2005, Boston, MA

Certifications

  • American Board of Otolaryngology (General)

Professional History

Margaret A. Kenna, MD, MPH, is a graduate of the Univ. of Pennsylvania (1974) and Boston University School of Medicine (1979). She completed her residency training in Otolaryngology-Head and Neck Surgery at the Univ. of Arkansas for Medical Sciences (1983) and fellowship in Pediatric Otolaryngology at the Children’s Hospital of Pittsburgh. Before coming to Boston, she was on the faculty at Children’s Hospital of Pittsburgh and Yale University School of Medicine. 

 Dr. Kenna has been on the Otolaryngology faculty at Boston Children’s Hospital since 1995. She co-founded the Children’s Hospital Boston Cochlear Implant Program, and was its Director from 1995-2003. Since 2003, she has been the Director of Clinical Research in the Dept. of Otolaryngology, Boston Children’s Hospital, and is Director of the Hearing Loss Program.  She completed a Master’s in Public Health degree (MPH) in the area of Clinical Effectiveness at the Harvard School of Public Health in 2005.

 

Dr. Kenna serves as an expert for the Department of Otolaryngology for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

Publications

  1. ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over time. Genet Med. 2025 Feb 19; 27(5):101392. View Abstract

  2. Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomes. NPJ Genom Med. 2024 Dec 02; 9(1):60. View Abstract

  3. Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss. Otolaryngol Head Neck Surg. 2025 Mar; 172(3):1006-1016. View Abstract

  4. Microbial DNA extraction method for avian feces and preen oil from diverse species. Ecol Evol. 2024 Sep; 14(9):e70220. View Abstract

  5. Chromosomal structural rearrangements implicate long non-coding RNAs in rare germline disorders. Hum Genet. 2024 Jul; 143(7):921-938. View Abstract

  6. Rare germline disorders implicate long non-coding RNAs disrupted by chromosomal structural rearrangements. medRxiv. 2024 Jun 19. View Abstract

  7. Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules. Science. 2024 04 26; 384(6694):eadf5489. View Abstract

  8. PKHD1L1, a gene involved in the stereocilia coat, causes autosomal recessive nonsyndromic hearing loss. Hum Genet. 2024 Mar; 143(3):311-329. View Abstract

  9. PKHD1L1, A Gene Involved in the Stereocilia Coat, Causes Autosomal Recessive Nonsyndromic Hearing Loss. medRxiv. 2023 Dec 19. View Abstract

  10. Models of Classroom Assessment for Course-Based Research Experiences. Front Educ (Lausanne). 2023; 8:1279921. View Abstract

  11. Vestibular Preservation in Pediatric Cochlear Implantation. Laryngoscope. 2024 04; 134(4):1913-1918. View Abstract

  12. Programming Levels and Speech Perception in Pediatric Cochlear Implant Recipients With Enlarged Vestibular Aqueduct or GJB2 Mutation. Otol Neurotol. 2023 06 01; 44(5):e273-e280. View Abstract

  13. Newborn Hearing Screening Results in Patients with Enlarged Vestibular Aqueduct. Laryngoscope. 2023 10; 133(10):2786-2791. View Abstract

  14. Exome Sequencing Expands the Genetic Diagnostic Spectrum for Pediatric Hearing Loss. Laryngoscope. 2023 09; 133(9):2417-2424. View Abstract

  15. Congenital Cytomegalovirus Screening in Massachusetts Birth Hospitals: A Statewide Survey. Int J Neonatal Screen. 2022 Dec 13; 8(4). View Abstract

  16. Otolaryngologic Manifestations of Trisomy 13 and Trisomy 18 in Pediatric Patients. Laryngoscope. 2023 06; 133(6):1501-1506. View Abstract

  17. Characterization of a possible founder synonymous variant in TECTA in multiple individuals with autosomal recessive hearing loss. Hum Mutat. 2022 12; 43(12):1837-1843. View Abstract

  18. Genetic testing for pediatric hearing loss: no time to waste. Hum Genet. 2022 Apr; 141(3-4):315-317. View Abstract

  19. In Response to, "Is revision of Cochlear Implants Infrequent?" Laryngoscope. 2022 05; 132(5):E17. View Abstract

  20. Hearing Stability in Patients With Unilateral Hearing Loss Due to Congenital CMV. Otolaryngol Head Neck Surg. 2022 10; 167(4):739-744. View Abstract

  21. Pain at the Cochlear Implant Site Requiring Device Removal in Pediatric Patients. Laryngoscope. 2022 10; 132(10):2044-2049. View Abstract

  22. Evaluation of copy number variants for genetic hearing loss: a review of current approaches and recent findings. Hum Genet. 2022 Apr; 141(3-4):387-400. View Abstract

  23. Peripheral Vestibular Dysfunction Is a Common Occurrence in Children With Non-syndromic and Syndromic Genetic Hearing Loss. Front Neurol. 2021; 12:714543. View Abstract

  24. Comprehensive medical evaluation of pediatric bilateral sensorineural hearing loss. Laryngoscope Investig Otolaryngol. 2021 Oct; 6(5):1196-1207. View Abstract

  25. Hearing Aid Use in Children With Unilateral Hearing Loss: A Randomized Crossover Clinical Trial. Laryngoscope. 2022 04; 132(4):881-888. View Abstract

  26. Neuroimaging in Kabuki syndrome and another KMT2D-related disorder. Am J Med Genet A. 2021 12; 185(12):3770-3783. View Abstract

  27. Hiding in plain sight: genetic deaf-blindness is not always Usher syndrome. Cold Spring Harb Mol Case Stud. 2021 08; 7(4). View Abstract

  28. Pediatric Bilateral Sensorineural Hearing Loss: Minimum Test Battery and Referral Criteria for Cochlear Implant Candidacy Evaluation. Otolaryngol Head Neck Surg. 2022 03; 166(3):405-409. View Abstract

  29. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss. Genet Med. 2021 11; 23(11):2208-2212. View Abstract

  30. Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish. Genet Med. 2021 10; 23(10):1933-1943. View Abstract

  31. Audiologic Phenotype and Progression in Pediatric STRC-Related Autosomal Recessive Hearing Loss. Laryngoscope. 2021 12; 131(12):E2897-E2903. View Abstract

  32. Review of Hearing Loss in Children-Reply. JAMA. 2021 03 23; 325(12):1224-1225. View Abstract

  33. Just Do It-Everyone Should Follow the Guidelines. JAMA Otolaryngol Head Neck Surg. 2021 03 01; 147(3):261-262. View Abstract

  34. Incidence, Time Course, and Implications of Electrode Abnormalities in Pediatric Cochlear Implant Recipients. Ear Hear. 2021 Mar/Apr; 42(2):334-342. View Abstract

  35. Dark-adapted threshold and electroretinogram for diagnosis of Usher syndrome. Doc Ophthalmol. 2021 08; 143(1):39-51. View Abstract

  36. A synonymous variant in MYO15A enriched in the Ashkenazi Jewish population causes autosomal recessive hearing loss due to abnormal splicing. Eur J Hum Genet. 2021 06; 29(6):988-997. View Abstract

  37. Hearing Loss in Children: A Review. JAMA. 2020 Dec 01; 324(21):2195-2205. View Abstract

  38. Does Ibuprofen Increase Bleed Risk for Pediatric Tonsillectomy? Otolaryngol Head Neck Surg. 2021 07; 165(1):187-196. View Abstract

  39. Women in Otolaryngology: Experiences of Being Female in the Specialty. Laryngoscope. 2021 02; 131(2):E380-E387. View Abstract

  40. Validation of a Parent Proxy Quality-of-Life Measure for Young Children With Hearing Loss. Laryngoscope. 2021 03; 131(3):663-670. View Abstract

  41. Genomic diversity of bacteriophages infecting Microbacterium spp. PLoS One. 2020; 15(6):e0234636. View Abstract

  42. Genetics of pediatric hearing loss: A functional perspective. Laryngoscope Investig Otolaryngol. 2020 Jun; 5(3):511-519. View Abstract

  43. Association of Blood Type With Postsurgical Mucosal Bleeding in Pediatric Patients Undergoing Tonsillectomy With or Without Adenoidectomy. JAMA Netw Open. 2020 03 02; 3(3):e201804. View Abstract

  44. Perspective on the Development of a Large-Scale Clinical Data Repository for Pediatric Hearing Research. Ear Hear. 2020 Mar/Apr; 41(2):231-238. View Abstract

  45. Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea. Hear Res. 2020 09 01; 394:107930. View Abstract

  46. Torticollis in children with enlarged vestibular aqueducts. Int J Pediatr Otorhinolaryngol. 2020 Apr; 131:109862. View Abstract

  47. Correction: ClinGen expert clinical validity curation of 164 hearing loss gene-disease pairs. Genet Med. 2019 Oct; 21(10):2409. View Abstract

  48. Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel. Genet Med. 2019 11; 21(11):2442-2452. View Abstract

  49. Genome Sequences of Six Cluster N Mycobacteriophages, Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob, Isolated on Mycobacterium smegmatis mc2155. Microbiol Resour Announc. 2019 May 30; 8(22). View Abstract

  50. A novel missense mutation in TFAP2B associated with Char syndrome and central diabetes insipidus. Am J Med Genet A. 2019 07; 179(7):1299-1303. View Abstract

  51. ClinGen expert clinical validity curation of 164 hearing loss gene-disease pairs. Genet Med. 2019 10; 21(10):2239-2247. View Abstract

  52. Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate. Mol Ther Methods Clin Dev. 2019 Jun 14; 13:1-13. View Abstract

  53. Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss. Hum Mutat. 2018 11; 39(11):1593-1613. View Abstract

  54. Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. Ann Otol Rhinol Laryngol. 2018 Oct; 127(10):687-693. View Abstract

  55. Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination. J Pediatr. 2018 10; 201:122-127.e1. View Abstract

  56. Postoperative Hearing Loss in a Patient With Crouzon Syndrome: A Case Report. A A Pract. 2018 Jun 01; 10(11):310-311. View Abstract

  57. Revision cochlear implant surgery in children: Surgical and audiological outcomes. Laryngoscope. 2018 11; 128(11):2619-2624. View Abstract

  58. Validation of a portable hearing assessment tool: Agilis Health Mobile Audiogram. Int J Pediatr Otorhinolaryngol. 2018 Oct; 113:94-98. View Abstract

  59. Otolaryngologic Manifestations of Klippel-Feil Syndrome in Children. JAMA Otolaryngol Head Neck Surg. 2018 Mar 01; 144(3):238-243. View Abstract

  60. Enlarged Vestibular Aqueduct and Cochlear Implants: The Effect of Early Counseling on the Length of Time Between Candidacy and Implantation. Otol Neurotol. 2018 02; 39(2):e90-e95. View Abstract

  61. Eight Genome Sequences of Cluster BE1 Phages That Infect Streptomyces Species. Genome Announc. 2018 Jan 11; 6(2). View Abstract

  62. Genome Sequences of Chancellor, Mitti, and Wintermute, Three Subcluster K4 Phages Isolated Using Mycobacterium smegmatis mc2155. Genome Announc. 2017 Nov 09; 5(45). View Abstract

  63. Tales of diversity: Genomic and morphological characteristics of forty-six Arthrobacter phages. PLoS One. 2017; 12(7):e0180517. View Abstract

  64. Neurologic Evaluation in Children With Laryngeal Cleft. JAMA Otolaryngol Head Neck Surg. 2017 07 01; 143(7):651-655. View Abstract

  65. Genome Sequences of Mycobacteriophages Jane and Sneeze, New Members of Cluster G. Genome Announc. 2017 Mar 16; 5(11). View Abstract

  66. Genome Sequence of Cluster W Mycobacteriophage Taptic. Genome Announc. 2017 Mar 16; 5(11). View Abstract

  67. Prophage-mediated defence against viral attack and viral counter-defence. Nat Microbiol. 2017 Jan 09; 2:16251. View Abstract

  68. Acute Otitis Media - The Long and the Short of It. N Engl J Med. 2016 12 22; 375(25):2492-2493. View Abstract

  69. Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. Arthritis Care Res (Hoboken). 2016 12; 68(12):1859-1865. View Abstract

  70. Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4. Laryngoscope. 2017 07; 127(7):E238-E243. View Abstract

  71. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol. 2016 Nov; 90:251-258. View Abstract

  72. Risk Factors for Hearing Loss in Patients with Cystic Fibrosis. J Am Acad Audiol. 2016 01; 27(1):6-12. View Abstract

  73. Atypical patterns of segregation of familial enlargement of the vestibular aqueduct. Laryngoscope. 2016 07; 126(7):E240-7. View Abstract

  74. Acquired Hearing Loss in Children. Otolaryngol Clin North Am. 2015 Dec; 48(6):933-53. View Abstract

  75. The Child with Hearing Loss. Otolaryngol Clin North Am. 2015 Dec; 48(6):xv-xvi. View Abstract

  76. Peripheral vestibular loss detected in pediatric patients using a smartphone-based test of the subjective visual vertical. Int J Pediatr Otorhinolaryngol. 2015 Dec; 79(12):2094-8. View Abstract

  77. The Public Health Impact of Pediatric Deep Neck Space Infections. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):1036-41. View Abstract

  78. Subjective visual vertical testing in children and adolescents. Laryngoscope. 2016 Mar; 126(3):727-31. View Abstract

  79. What is the best non-codeine postadenotonsillectomy pain management for children? Laryngoscope. 2014 Aug; 124(8):1737-8. View Abstract

  80. A121: in search of infectious triggers of periodic Fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S158. View Abstract

  81. Use of SLC26A4 mutation testing for unilateral enlargement of the vestibular aqueduct. JAMA Otolaryngol Head Neck Surg. 2013 Sep; 139(9):907-13. View Abstract

  82. 3 µm CW lasers for myringotomy and microsurgery. Proc SPIE Int Soc Opt Eng. 2013 Mar 08; 8565. View Abstract

  83. Pediatric sudden sensorineural hearing loss: diagnosed causes and response to intervention. Int J Pediatr Otorhinolaryngol. 2013 Apr; 77(4):553-9. View Abstract

  84. Long-term surgical outcomes of adenotonsillectomy for PFAPA syndrome. Arch Otolaryngol Head Neck Surg. 2012 Oct; 138(10):902-6. View Abstract

  85. Frequent association of cochlear nerve canal stenosis with pediatric sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2012 Apr; 138(4):383-388. View Abstract

  86. Prognosis tool based on a modified children's implant profile for use in pediatric cochlear implant candidacy evaluation. Ann Otol Rhinol Laryngol. 2012 Feb; 121(2):73-84. View Abstract

  87. Genome-wide SNP genotyping identifies the Stereocilin (STRC) gene as a major contributor to pediatric bilateral sensorineural hearing impairment. Am J Med Genet A. 2012 Feb; 158A(2):298-308. View Abstract

  88. Retinal disease course in Usher syndrome 1B due to MYO7A mutations. Invest Ophthalmol Vis Sci. 2011 Oct 07; 52(11):7924-36. View Abstract

  89. Clinical experience in diagnosis and management of superior semicircular canal dehiscence in children. Laryngoscope. 2011 Oct; 121(10):2256-61. View Abstract

  90. Enlarged vestibular aqueduct: review of controversial aspects. Laryngoscope. 2011 Sep; 121(9):1971-8. View Abstract

  91. Comparison of postoperative pain in pediatric patients undergoing coblation tonsillectomy versus cautery tonsillectomy. Otolaryngol Head Neck Surg. 2011 Jun; 144(6):972-7. View Abstract

  92. Histopathologic investigation of the dimensions of the cochlear nerve canal in normal temporal bones. Int J Pediatr Otorhinolaryngol. 2011 Apr; 75(4):464-7. View Abstract

  93. Temporal bone abnormalities in children with GJB2 mutations. Laryngoscope. 2011 Mar; 121(3):630-5. View Abstract

  94. Is computed tomography (CT) or magnetic resonance imaging (MRI) more useful in the evaluation of pediatric sensorineural hearing loss? Laryngoscope. 2010 Dec; 120(12):2358-9. View Abstract

  95. Not a "sound" decision: is cochlear implantation always the best choice? Int J Pediatr Otorhinolaryngol. 2010 Oct; 74(10):1144-8. View Abstract

  96. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnol. 2010 Feb 10; 10:10. View Abstract

  97. Posterior semicircular canal dehiscence: first reported case series. Otol Neurotol. 2010 Feb; 31(2):339-44. View Abstract

  98. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg. 2010 Jan; 136(1):81-7. View Abstract

  99. Sensorineural hearing loss in patients with cystic fibrosis. Otolaryngol Head Neck Surg. 2009 Jul; 141(1):86-90. View Abstract

  100. Distinct and novel SLC26A4/Pendrin mutations in Chinese and U.S. patients with nonsyndromic hearing loss. Physiol Genomics. 2009 Aug 07; 38(3):281-90. View Abstract

  101. Disturbance of vestibular function attributable to cochlear implantation in children. Laryngoscope. 2009 Apr; 119(4):740-5. View Abstract

  102. Assessment of saccular function in children with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2009 Jan; 135(1):40-4. View Abstract

  103. Delineating the hearing loss in children with enlarged vestibular aqueduct. Laryngoscope. 2008 Nov; 118(11):2062-6. View Abstract

  104. Use of a preoperative bleeding questionnaire in pediatric patients who undergo adenotonsillectomy. Otolaryngol Head Neck Surg. 2008 Oct; 139(4):546-550. View Abstract

  105. Phosphorylcholine-coated antibiotic tympanostomy tubes: are post-tube placement complications reduced? Int J Pediatr Otorhinolaryngol. 2008 Sep; 72(9):1323-8. View Abstract

  106. Music to your ears: is it a good thing? Acta Paediatr. 2008 Feb; 97(2):151-2. View Abstract

  107. Effect of adenotonsillectomy in PFAPA syndrome. Arch Otolaryngol Head Neck Surg. 2008 Feb; 134(2):136-40. View Abstract

  108. Additional clinical manifestations in children with sensorineural hearing loss and biallelic GJB2 mutations: who should be offered GJB2 testing? Am J Med Genet A. 2007 Jul 15; 143A(14):1560-6. View Abstract

  109. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007 Jul; 9(7):413-26. View Abstract

  110. Anomalies of the middle and inner ear. Otolaryngol Clin North Am. 2007 Feb; 40(1):81-96, vi. View Abstract

  111. The nuclear envelope and spindle pole body-associated Mps3 protein bind telomere regulators and function in telomere clustering. Cell Cycle. 2007 Jan 01; 6(1):75-9. View Abstract

  112. Intersection between the regulators of sister chromatid cohesion establishment and maintenance in budding yeast indicates a multi-step mechanism. Cell Cycle. 2006 Nov 01; 5(21):2528-36. View Abstract

  113. Pediatric adenoidectomy: what is the effect of obstructive symptoms on the likelihood of future surgery? Int J Pediatr Otorhinolaryngol. 2006 Aug; 70(8):1467-72. View Abstract

  114. The use of perioperative antibiotics in tonsillectomy: does it decrease morbidity? Int J Pediatr Otorhinolaryngol. 2006 May; 70(5):853-61. View Abstract

  115. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. 2005 Dec; 77(6):945-57. View Abstract

  116. Pediatric facial nerve paralysis: patients, management and outcomes. Int J Pediatr Otorhinolaryngol. 2005 Nov; 69(11):1521-8. View Abstract

  117. Otitis media and the new guidelines. J Otolaryngol. 2005 Jun; 34 Suppl 1:S24-32. View Abstract

  118. Combined microtia and aural atresia: issues in cochlear implantation. Laryngoscope. 2005 Jan; 115(1):39-43. View Abstract

  119. Medical management of childhood hearing loss. Pediatr Ann. 2004 Dec; 33(12):822-32. View Abstract

  120. The spindle pole body assembly component mps3p/nep98p functions in sister chromatid cohesion. J Biol Chem. 2004 Nov 19; 279(47):49542-50. View Abstract

  121. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2004 May; 130(5 Suppl):S95-118. View Abstract

  122. Human EFO1p exhibits acetyltransferase activity and is a unique combination of linker histone and Ctf7p/Eco1p chromatid cohesion establishment domains. Nucleic Acids Res. 2003 Nov 01; 31(21):6334-43. View Abstract

  123. Extraesophageal reflux in pediatric patients with upper respiratory symptoms. Arch Otolaryngol Head Neck Surg. 2003 Nov; 129(11):1213-20. View Abstract

  124. Use of a multiplex PCR/sequencing strategy to detect both connexin 30 (GJB6) 342 kb deletion and connexin 26 (GJB2) mutations in cases of childhood deafness. Am J Med Genet A. 2003 Aug 30; 121A(2):102-8. View Abstract

  125. Utility of tonsillectomy in 2 patients with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Arch Otolaryngol Head Neck Surg. 2003 Jun; 129(6):670-3. View Abstract

  126. Mechanical link between cohesion establishment and DNA replication: Ctf7p/Eco1p, a cohesion establishment factor, associates with three different replication factor C complexes. Mol Cell Biol. 2003 Apr; 23(8):2999-3007. View Abstract

  127. The presentation and management of nasal dermoid: a 30-year experience. Arch Otolaryngol Head Neck Surg. 2003 Apr; 129(4):464-71. View Abstract

  128. Neonatal hearing screening. Pediatr Clin North Am. 2003 Apr; 50(2):301-13. View Abstract

  129. Effectiveness of sequencing connexin 26 (GJB2) in cases of familial or sporadic childhood deafness referred for molecular diagnostic testing. Genet Med. 2002 Jul-Aug; 4(4):279-88. View Abstract

  130. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? Arch Otolaryngol Head Neck Surg. 2002 Apr; 128(4):401-6. View Abstract

  131. Congenital absence of the incus bilaterally without other otologic anomalies: a new case report. Ear Nose Throat J. 2002 Apr; 81(4):274-6, 278. View Abstract

  132. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2001 Sep; 127(9):1037-42. View Abstract

  133. Mediastinitis associated with foreign body erosion of the esophagus in children. Int J Pediatr Otorhinolaryngol. 2001 Jun 07; 59(2):89-97. View Abstract

  134. Craniofacial, temporal bone, and audiologic abnormalities in the spectrum of hemifacial microsomia. Arch Otolaryngol Head Neck Surg. 2001 Mar; 127(3):265-71. View Abstract

  135. The relationship between dental overbite and eustachian tube dysfunction. Laryngoscope. 2001 Feb; 111(2):310-6. View Abstract

  136. Airway foreign bodies (FB): a 10-year review. Int J Pediatr Otorhinolaryngol. 2000 Dec 01; 56(2):91-9. View Abstract

  137. Intraoperative recurrent laryngeal nerve monitoring during video-assisted throracoscopic surgery for patent ductus arteriosus. J Cardiothorac Vasc Anesth. 2000 Oct; 14(5):562-4. View Abstract

  138. Otitis media: the otolaryngologist's perspective. Pediatr Ann. 2000 Oct; 29(10):630-6. View Abstract

  139. Pathology forum: quiz case 1. Diagnosis: posttransplant lymphoproliferative disease (PTLD) of the epiglottis. Arch Otolaryngol Head Neck Surg. 2000 Sep; 126(9):1153; discussion 1157-8. View Abstract

  140. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci U S A. 2000 Jun 06; 97(12):6658-63. View Abstract

  141. Don't rely on the surgical airway: a case of impossible tracheostomy. Paediatr Anaesth. 2000; 10(2):224-5. View Abstract

  142. Cochlear implants and the deaf child: a nursing perspective. Pediatr Nurs. 1999 Jul-Aug; 25(4):396-400, 444. View Abstract

  143. Acupressure-acupuncture antiemetic prophylaxis in children undergoing tonsillectomy. Anesthesiology. 1999 May; 90(5):1311-6. View Abstract

  144. Causes of pediatric sensorineural hearing loss: yesterday and today. Arch Otolaryngol Head Neck Surg. 1999 May; 125(5):517-21. View Abstract

  145. Necrotizing fasciitis of the pharynx following adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 1999 Apr 25; 48(1):1-7. View Abstract

  146. Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology. J Neuropathol Exp Neurol. 1998 Dec; 57(12):1190-201. View Abstract

  147. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol. 1998 Oct; 107(10 Pt 1):865-71. View Abstract

  148. Comparison of spectral gradient acoustic reflectometry and other diagnostic techniques for detection of middle ear effusion in children with middle ear disease. Pediatr Infect Dis J. 1998 Jun; 17(6):556-9; discussion 580. View Abstract

  149. Invading the yeast nucleus: a nuclear localization signal at the C terminus of Ty1 integrase is required for transposition in vivo. Mol Cell Biol. 1998 Feb; 18(2):1115-24. View Abstract

  150. Cochlear implantation in children. Nurs Clin North Am. 1997 Mar; 32(1):97-107. View Abstract

  151. Yeast N1e3p/Nup170p is required for normal stoichiometry of FG nucleoporins within the nuclear pore complex. Mol Cell Biol. 1996 May; 16(5):2025-36. View Abstract

  152. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Am J Otol. 1996 Mar; 17(2):207-9. View Abstract

  153. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg. 1995 Sep; 121(9):1022-5. View Abstract

  154. Pathologic quiz case 1. Granular cell tumor (GCT) of larynx. Arch Otolaryngol Head Neck Surg. 1995 Sep; 121(9):1058, 1060-1. View Abstract

  155. Head and neck manifestations of Beckwith-Wiedemann syndrome. Otolaryngol Head Neck Surg. 1995 Sep; 113(3):262-5. View Abstract

  156. Correlation of beta-2 transferrin and middle ear abnormalities in congenital perilymphatic fistula. Am J Otol. 1995 May; 16(3):277-82. View Abstract

  157. Consultation with the specialist. Hoarseness. Pediatr Rev. 1995 Feb; 16(2):69-72. View Abstract

  158. Genetic and physical interactions between Srp1p and nuclear pore complex proteins Nup1p and Nup2p. J Cell Biol. 1994 Aug; 126(3):619-30. View Abstract

  159. Treatment of chronic suppurative otitis media. Otolaryngol Clin North Am. 1994 Jun; 27(3):457-72. View Abstract

  160. Sensorineural hearing loss from quinolinic acid: a neurotoxin in middle ear effusions. Laryngoscope. 1994 Feb; 104(2):176-81. View Abstract

  161. Medical management of chronic suppurative otitis media without cholesteatoma in children--update 1992. Am J Otol. 1993 Sep; 14(5):469-73. View Abstract

  162. Laryngeal cysts: a cause of neonatal airway obstruction. Otolaryngol Head Neck Surg. 1993 Jul; 109(1):129-34. View Abstract

  163. An essential yeast gene with homology to the exonuclease-encoding XRN1/KEM1 gene also encodes a protein with exoribonuclease activity. Mol Cell Biol. 1993 Jan; 13(1):341-50. View Abstract

  164. Adenotonsillectomy for upper airway obstruction carries increased risk in children with a history of prematurity. Pediatr Pulmonol. 1992 Aug; 13(4):222-6. View Abstract

  165. The effect of gastroesophageal reflux on the pediatric airway. Int Anesthesiol Clin. 1992; 30(4):83-91. View Abstract

  166. Surgical management of tracheal stenosis in an infant with multiple congenital anomalies: when is baby inoperable? Ann Otol Rhinol Laryngol. 1991 Mar; 100(3):198-200. View Abstract

  167. Congenital perilymphatic fistula: an overlooked diagnosis? Am J Otol. 1989 Nov; 10(6):496-8. View Abstract

  168. The structure of a primitive kinetochore. Trends Biochem Sci. 1989 Jun; 14(6):223-7. View Abstract

  169. Cis- and trans-acting factors affecting the structure of yeast centromeres. J Cell Sci Suppl. 1989; 12:231-42. View Abstract

  170. Selective excision of the centromere chromatin complex from Saccharomyces cerevisiae. J Cell Biol. 1988 Jul; 107(1):9-15. View Abstract

  171. Foreign bodies in the air and food passages. Pediatr Rev. 1988 Jul; 10(1):25-31. View Abstract

  172. Refractory torticollis: an uncommon complication of adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 1987 Dec; 14(2-3):87-93. View Abstract

  173. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children. Pediatr Infect Dis J. 1987 Oct; 6(10):992-6. View Abstract

  174. Prognostic value of eustachian tube function in pediatric tympanoplasty. Laryngoscope. 1987 Sep; 97(9):1012-6. View Abstract

  175. Tracheotomy in the preterm infant. Ann Otol Rhinol Laryngol. 1987 Jan-Feb; 96(1 Pt 1):68-71. View Abstract

  176. Duration of intubation in children with acute epiglottitis. Otolaryngol Head Neck Surg. 1986 Nov; 95(4):477-81. View Abstract

  177. Junctional epidermolysis bullosa of the larynx. Pediatrics. 1986 Jul; 78(1):172-4. View Abstract

  178. Microbiology of chronic suppurative otitis media in children. Pediatr Infect Dis. 1986 Mar-Apr; 5(2):223-5. View Abstract

  179. Complication of acute epiglottitis. Int J Pediatr Otorhinolaryngol. 1986 Feb; 11(1):67-71. View Abstract

  180. Medical management of chronic suppurative otitis media without cholesteatoma in children. Laryngoscope. 1986 Feb; 96(2):146-51. View Abstract

  181. Nasal surgery in children with cystic fibrosis: complications and risk management. Laryngoscope. 1985 Dec; 95(12):1491-3. View Abstract

  182. Consensus: management of the child with a chronic draining ear. Pediatr Infect Dis. 1985 Nov-Dec; 4(6):607-12. View Abstract

  183. Tidal flow measurement in the decision to decannulate the pediatric patient. Ann Otol Rhinol Laryngol. 1985 Sep-Oct; 94(5 Pt 1):454-7. View Abstract

  184. Transsphenoidal encephalocele. Ann Otol Rhinol Laryngol. 1985 Sep-Oct; 94(5 Pt 1):520-2. View Abstract

  185. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. Cancer Res. 1985 Sep; 45(9):4433-8. View Abstract

  186. Effectiveness of hydrotreatment in reducing the toxicity of a coal liquefaction product to juvenile channel catfish. Bull Environ Contam Toxicol. 1985 May; 34(5):746-53. View Abstract

  187. Nasal papillomas and squamous carcinoma. Am Fam Physician. 1984 Sep; 30(3):171-5. View Abstract

  188. Chronic suppurative otitis media: antimicrobial therapy or surgery? Pediatr Ann. 1984 May; 13(5):417-21. View Abstract

  189. Malignant granular cell tumor of the tongue. Arch Otolaryngol. 1982 Sep; 108(9):603-5. View Abstract

  190. Concanavalin A-mediated binding and sphering of human red blood cells by homologous monocytes. J Exp Med. 1976 Dec 01; 144(6):1695-700. View Abstract

  191. Effect of papain on the interaction between human monocytes, erythrocytes, and IgG. Blood. 1975 Aug; 46(2):245-52. View Abstract

  192. Drugs in child psychotherapy. Curr Psychiatr Ther. 1969; 9:26-31. View Abstract
BESbswy
BESbswy